This text provides a state-of-the-art overview on Non-Hodgkin's lymphoma (NHL) in children and adolescents. The volume is divided into seven sections, each of which focuses on a critical component of pediatric NHL, including history and epidemiology, pathology and molecular biology, disease evaluation and response, common and rare sub-types of NHL, and current and novel treatment strategies. The text also comprehensively reviews the late effects of treatment, quality of patient life, and NHL treatment in countries with limited resources.
Written by experts in the field, Non-Hodgkin's Lymphoma in Childhood and Adolescence is a valuable resource for clinicians and practitioners who treat children and adolescents with NHL.

History of Diagnoses and Treatment Strategies in Pediatric Non-Hodgkin's Lymphomas

Epidemiology of Non-Hodgkin Lymphomas in Childhood and Adolescence
Diagnosis and Classification
Pathogenesis of B-cell Lymphoma
Pathogenesis of T-Non-Hodgkin's Lymphoma
Pathogenesis of Anaplastic Large Cell Lymphoma
Pathology
Genetic Predisposition to Non-Hodgkin Lymphoma
Response Assessment in Pediatric Non-Hodgkin Lymphoma
Minimal Disseminated and Minimal Residual Disease in Pediatric Non-Hodgkin Lymphoma
Prognostic Factors in Childhood and Adolescent Non-Hodgkin Lymphoma
Lymphoblastic Lymphoma
Burkitt's Lymphoma and Diffuse Large B-cell Lymphoma
Primary Mediastinal and Gray Zone Lymphomas
Epstein-Barr Virus-associated Post-transplantation Lymphoproliferative Disease
Pediatric-Type Follicular Lymphoma (PTFL)
Marginal Zone Lymphoma
Primary Central Nervous System Lymphoma (PCNSL)
Rare B-cell non-Hodgkin's Lymphomas (B-NHL) in Childhood and Adolescence
Anaplastic Large Cell Lymphoma in Children and Adolescents
Peripheral T-cell Lymphoma
Extranodal NK/T cell lymphomas and EBV+ Lymphoproliferative Diseases of Childhood
Cutaneous T-cell Lymphomas in Childhood and Adolescence
Principles of Immunotherapy
Hematopoietic Stem Cell Transplantation
Novel Therapies in Pediatric NHL
Childhood and Adolescence Non-Hodgkin Lymphomas in Low- and Middle-Income Countries
Long-Term Outcomes in Survivors of Childhood and Adolescent Non-Hodgkin Lymphoma.